Published by Michael O'Regan
March 26, 2020
As some countries begin to ease social distancing restrictions and many more consider such moves, the WHO is urging caution on the basis of current knowledge that COVID-19 accelerates quickly but appears to decelerate much more slowly. Whatever decisions national governments take regarding a return to more normal activity, there is a general consensus that we will have to live with this coronavirus for many months, and perhaps years, to come. Guidance from national health authorities, such as the US CDC, has brought home to employers the importance of ongoing health monitoring of core workforces in order to ensure continuity of operations. Such an undertaking should be evidence-based and be resource-efficient in terms of evidence generation, aggregation and analysis.
The end-goal of any Regen Med Project is not to consult; it is to provide a turnkey, evidence-based solution. In this case, we work with our Client to generate relevant and timely evidence from ongoing COVID-related health monitoring of the Client’s employees. The objective is to avoid disruption of operations due to the spread of the virus within the workforce.
Achieving this result requires, as the initial step, a focused interaction with one or more representatives of the Client to coordinate with Regen Med on the Project Design and its implementation. This Working Group will:
Select the employee groups to be included in the project and identify Corporate Coordinators and Team Members to involve and their various levels of data access permission.
Timing and Implementation
Project Design Steps 1 – 5: Two to four working weeks.
Project Design Steps 6 – 9: Two to four working weeks. Some steps may be executed in parallel with prior steps.
Regen Med to provide all:
It is the goal of Regen Med to show concrete results as soon as possible in addressing the specific issue underlying a given Project. The Project Design phase requires the active involvement of Client representatives, but the implementation phase can largely be undertaken by Regen Med.
Budget depends on the final Project Design. To a substantial extent, Regen Med prices its services to correspond to achievement of concrete KPI’s reflecting that design.
WHO Director-General’s opening remarks at the media briefing on COVID-19 – 13 April 2020
Interim Guidance for Businesses and Employers to Plan and Respond to Coronavirus Disease 2019 (COVID-19). Plan, Prepare and Respond to Coronavirus Disease 2019
OPEN ENTERPRISES, PROTECTED WORKERS: A PROJECT TO START PHASE 2; Turin Polytechnic University, Italy; April 17, 2020
‘Back on Track’, Ferrari’s project to protect the health of employees upon the restart of production
March 28, 2023
Statistical Significance and Clinical Relevance are two important concepts in the field of medicine, and particularly in clinical research. Being a bit more specific, statistical significance refers to the likelihood that a result is not due to chance.
March 17, 2023
Real-world evidence (RWE) is valuable not only for regulatory compliance, clinical decision-making and tracking adverse events. It can also drive patient engagement, profitability and professional advancement.
January 27, 2023
In this newsletter, we summarize the work of leading physicians as they develop clinical decision support for common musculoskeletal pathologies. Through the quality improvement and pragmatic studies embedded in their Circles, those clinicians are generating sustained financial and professional value for themselves, and improving patient care, with minimum burden. Moreover, their Circles are often supported by industry.